NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

生物製藥的全球市場(2021年∼2025年)

Global Biologic Therapeutics Market 2021-2025

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 1023665
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
生物製藥的全球市場(2021年∼2025年) Global Biologic Therapeutics Market 2021-2025
出版日期: 2021年06月14日內容資訊: 英文 120 Pages
簡介

生物製藥的市場規模在2021年∼2025年的預測期間內,預計將以11.00%的年複合成長率推移,並成長到2,266億1,000萬美元。

生物製藥市場相關之本報告提供整體分析,市場規模與預測,趨勢,涵括成長要素,課題,以及約25位供應商的供應商分析。

市場成長的主要因素有強力的研究開發平台,主要的生物製藥的專利到期,生物製藥開發的投資的增加等。

本報告提供生物製藥市場調查,市場概要,市場規模,市場預測,客戶形勢,各產品·各地區的分析,再加上業者情勢和供應商分析等。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2020年
  • 市場預測:從2020年∼2025年的預測

波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

各產品的市場區隔

  • 市場區隔
  • 各產品比較
  • 抗體療法:市場規模與預測(2020年∼2025年)
  • 疫苗:市場規模與預測(2020年∼2025年)
  • 細胞治療:市場規模與預測(2020年∼2025年)
  • 基因治療:市場規模與預測(2020年∼2025年)
  • 其他治療方法:市場規模與預測(2020年∼2025年)
  • 各產品的市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2020年∼2025年)
  • 歐洲:市場規模與預測(2020年∼2025年)
  • 亞洲:市場規模與預測(2020年∼2025年)
  • 其他地區:市場規模與預測(2020年∼2025年)
  • 主要國家
  • 各地區形勢市場機會
  • 市場成長促進因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

附錄

目錄
Product Code: IRTNTR44341

Technavio has been monitoring the biologic therapeutics market and it is poised to grow by $ 226.61 bn during 2021-2025, progressing at a CAGR of 11.00% during the forecast period. Our report on the biologic therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by strong R&D pipeline, patent expiry of major biologics, and increasing investment in development of biologics. In addition, strong R&D pipeline is anticipated to boost the growth of the market as well.

The biologic therapeutics market analysis includes product and geographic landscape.

Technavio's biologic therapeutics market is segmented as below:

By Product

  • Antibody therapeutics
  • Vaccines
  • Cell therapy
  • Gene therapy
  • Other therapies

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the introduction of biosimilars as one of the prime reasons driving the biologic therapeutics market growth during the next few years. Also, the increasing incidence of chronic diseases and immunological disorders and patent expiry of major biologics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on biologic therapeutics market covers the following areas:

  • Biologic therapeutics market sizing
  • Biologic therapeutics market forecast
  • Biologic therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologic therapeutics market vendors that include AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the biologic therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Antibody therapeutics - Market size and forecast 2020-2025
    • Vaccines - Market size and forecast 2020-2025
    • Cell therapy - Market size and forecast 2020-2025
    • Gene therapy - Market size and forecast 2020-2025
    • Other therapies - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • AbbVie Inc.
    • AstraZeneca Plc
    • Bristol-Myers Squibb Co.
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline Plc
    • Johnson and Johnson Inc.
    • Merck and Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations
  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ billion)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Antibody therapeutics - Market size and forecast 2020-2025 ($ billion)
  • 24: Antibody therapeutics - Year-over-year growth 2020-2025 (%)
  • 25: Vaccines - Market size and forecast 2020-2025 ($ billion)
  • 26: Vaccines - Year-over-year growth 2020-2025 (%)
  • 27: Cell therapy - Market size and forecast 2020-2025 ($ billion)
  • 28: Cell therapy - Year-over-year growth 2020-2025 (%)
  • 29: Gene therapy - Market size and forecast 2020-2025 ($ billion)
  • 30: Gene therapy - Year-over-year growth 2020-2025 (%)
  • 31: Other therapies - Market size and forecast 2020-2025 ($ billion)
  • 32: Other therapies - Year-over-year growth 2020-2025 (%)
  • 33: Market opportunity by Product
  • 34: Customer landscape
  • 35: Market share By Geographical Landscape 2020-2025 (%)
  • 36: Geographic comparison
  • 37: North America - Market size and forecast 2020-2025 ($ billion)
  • 38: North America - Year-over-year growth 2020-2025 (%)
  • 39: Europe - Market size and forecast 2020-2025 ($ billion)
  • 40: Europe - Year-over-year growth 2020-2025 (%)
  • 41: Asia - Market size and forecast 2020-2025 ($ billion)
  • 42: Asia - Year-over-year growth 2020-2025 (%)
  • 43: ROW - Market size and forecast 2020-2025 ($ billion)
  • 44: ROW - Year-over-year growth 2020-2025 (%)
  • 45: Key leading countries
  • 46: Market opportunity By Geographical Landscape ($ billion)
  • 47: Impact of drivers and challenges
  • 48: Vendor landscape
  • 49: Landscape disruption
  • 50: Industry risks
  • 51: Vendors covered
  • 52: Market positioning of vendors
  • 53: AbbVie Inc. - Overview
  • 54: AbbVie Inc. - Product and service
  • 55: AbbVie Inc. - Key offerings
  • 56: AbbVie Inc. - Key customers
  • 57: AbbVie Inc. - Segment focus
  • 58: AstraZeneca Plc - Overview
  • 59: AstraZeneca Plc - Product and service
  • 60: AstraZeneca Plc - Key offerings
  • 61: AstraZeneca Plc - Key customers
  • 62: AstraZeneca Plc - Segment focus
  • 63: Bristol-Myers Squibb Co. - Overview
  • 64: Bristol-Myers Squibb Co. - Product and service
  • 65: Bristol-Myers Squibb Co. - Key offerings
  • 66: Bristol-Myers Squibb Co. - Key customers
  • 67: Bristol-Myers Squibb Co. - Segment focus
  • 68: F. Hoffmann-La Roche Ltd. - Overview
  • 69: F. Hoffmann-La Roche Ltd. - Business segments
  • 70: F. Hoffmann-La Roche Ltd. - Key offerings
  • 71: F. Hoffmann-La Roche Ltd. - Key customers
  • 72: F. Hoffmann-La Roche Ltd. - Segment focus
  • 73: GlaxoSmithKline Plc - Overview
  • 74: GlaxoSmithKline Plc - Business segments
  • 75: GlaxoSmithKline Plc - Key offerings
  • 76: GlaxoSmithKline Plc - Key customers
  • 77: GlaxoSmithKline Plc - Segment focus
  • 78: Johnson and Johnson Inc. - Overview
  • 79: Johnson and Johnson Inc. - Business segments
  • 80: Johnson and Johnson Inc. - Key offerings
  • 81: Johnson and Johnson Inc. - Key customers
  • 82: Johnson and Johnson Inc. - Segment focus
  • 83: Merck and Co. Inc. - Overview
  • 84: Merck and Co. Inc. - Business segments
  • 85: Merck and Co. Inc. - Key offerings
  • 86: Merck and Co. Inc. - Key customers
  • 87: Merck and Co. Inc. - Segment focus
  • 88: Novartis AG - Overview
  • 89: Novartis AG - Business segments
  • 90: Novartis AG - Key offerings
  • 91: Novartis AG - Key customers
  • 92: Novartis AG - Segment focus
  • 93: Pfizer Inc. - Overview
  • 94: Pfizer Inc. - Business segments
  • 95: Pfizer Inc. - Key offerings
  • 96: Pfizer Inc. - Key customers
  • 97: Pfizer Inc. - Segment focus
  • 98: Sanofi SA - Overview
  • 99: Sanofi SA - Business segments
  • 100: Sanofi SA - Key offerings
  • 101: Sanofi SA - Key customers
  • 102: Sanofi SA - Segment focus
  • 103: Currency conversion rates for US$
  • 104: Research Methodology
  • 105: Validation techniques employed for market sizing
  • 106: Information sources
  • 107: List of abbreviations